Saudi Arabia and the United Arab Emirates continue to lead healthcare investments across the Gulf region. According to JLL, both countries accounted for nearly 92 percent of transactions recorded between 2021 and April 2025. The dominance of healthcare deals in GCC underscores their role in transforming regional healthcare.
The UAE secured 198 transactions during the period, while Saudi Arabia followed closely with 170. Analysts link this momentum to national transformation programs such as Vision 2030 in Saudi Arabia and the UAE’s Ministry of Health and Prevention strategy. These initiatives focus on expanding healthcare infrastructure, attracting investors, and modernizing systems.
JLL reported that demographic growth, rapid digital adoption, and government-led reforms remain the main drivers of investment. Young, tech-savvy populations are fueling demand for wellness and preventive care, while aging communities require advanced treatments and long-term care. As a result, healthcare deals in GCC continue to multiply across diverse sectors.
Recent studies project the healthcare innovation market in the GCC to expand from $121.9 billion in 2025 to $170.5 billion by 2030. This growth is fueled by increasing investment in digital health, telemedicine, artificial intelligence diagnostics, and biotechnology.
Saudi Arabia has signed high-impact memoranda of understanding with global healthcare leaders, including Germfree and Illumina. These partnerships focus on localizing laboratory manufacturing and advancing genomics research. Meanwhile, the UAE has accelerated digital transformation with its Riayati platform, which streamlines patient access and medical records.
JLL data revealed 170 early-stage funding rounds and 91 mergers and acquisitions since 2021. Many of these targeted health-tech startups, outpatient clinics, and wellness services. Hospitals and clinics accounted for 28 percent of M&A activity, showing steady consolidation in the sector.
Sovereign wealth funds like Mubadala and ADQ have also driven major acquisitions. Sovereign wealth funds added companies such as Diabtec, Gulf Inject, and Well Pharma Medical Solutions to their portfolios. IPO activity has matured, with Saudi Arabia’s Almoosa Health raising $450 million in 2025.
Looking ahead, investors are expected to prioritize preventive healthcare, personalized medicine, and AI-driven solutions. Analysts believe healthcare deals in GCC will continue shaping the region’s economic future while transforming patient care.
